Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$0.5 - $0.72 $27 - $39
55 Added 785.71%
62 $0
Q2 2023

Aug 04, 2023

BUY
$0.62 - $0.87 $4 - $6
7 New
7 $0
Q4 2022

Feb 02, 2023

SELL
$0.77 - $1.62 $860 - $1,809
-1,117 Reduced 12.1%
8,116 $6,000
Q3 2022

Nov 04, 2022

BUY
$1.79 - $2.96 $11,334 - $18,742
6,332 Added 218.27%
9,233 $15,000
Q2 2022

Aug 03, 2022

SELL
$1.65 - $3.13 $8,329 - $15,800
-5,048 Reduced 63.5%
2,901 $7,000
Q1 2022

May 02, 2022

SELL
$2.1 - $3.54 $35,403 - $59,680
-16,859 Reduced 67.96%
7,949 $24,000
Q4 2021

Feb 23, 2022

BUY
$3.04 - $6.01 $75,416 - $149,096
24,808 New
24,808 $75,000
Q2 2021

Aug 12, 2021

SELL
$5.78 - $9.6 $41,829 - $69,475
-7,237 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$5.67 - $12.54 $41,033 - $90,751
7,237 New
7,237 $52,000

Others Institutions Holding NHWK

About NightHawk Biosciences, Inc.


  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.